[
  {
    "ts": null,
    "headline": "Boston Scientific, U.S. Physical Therapy, 10x Genomics, GE HealthCare, and Integer Holdings Shares Are Falling, What You Need To Know",
    "summary": "A number of stocks fell in the afternoon session after markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflation reading.",
    "url": "https://finnhub.io/api/news?id=e6697b144c5a0b94bac595cd75e2addb4af66b34ced295cfc1d5cc7172b12804",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757545244,
      "headline": "Boston Scientific, U.S. Physical Therapy, 10x Genomics, GE HealthCare, and Integer Holdings Shares Are Falling, What You Need To Know",
      "id": 136689244,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "A number of stocks fell in the afternoon session after markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflation reading.",
      "url": "https://finnhub.io/api/news?id=e6697b144c5a0b94bac595cd75e2addb4af66b34ced295cfc1d5cc7172b12804"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors",
    "summary": "The latest trading day saw Boston Scientific (BSX) settling at $105.23, representing a -2.65% change from its previous close.",
    "url": "https://finnhub.io/api/news?id=bffc886fafcc55969828fa823f8c9c4575af5c7a7be78fe253f2305bfb516382",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757545202,
      "headline": "Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors",
      "id": 136689245,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "The latest trading day saw Boston Scientific (BSX) settling at $105.23, representing a -2.65% change from its previous close.",
      "url": "https://finnhub.io/api/news?id=bffc886fafcc55969828fa823f8c9c4575af5c7a7be78fe253f2305bfb516382"
    }
  },
  {
    "ts": null,
    "headline": "Reasons to Retain Avanos Medical Stock in Your Portfolio Now",
    "summary": "AVNS's solid Q2 performance, strong product demand, and strategic transformation support growth amid tariff and FX headwinds.",
    "url": "https://finnhub.io/api/news?id=51859f0f156c5e7171cd8472e4debb52a0cbd8a7de804ab6ee618b4f97e1ea55",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757525700,
      "headline": "Reasons to Retain Avanos Medical Stock in Your Portfolio Now",
      "id": 136689246,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "AVNS's solid Q2 performance, strong product demand, and strategic transformation support growth amid tariff and FX headwinds.",
      "url": "https://finnhub.io/api/news?id=51859f0f156c5e7171cd8472e4debb52a0cbd8a7de804ab6ee618b4f97e1ea55"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Corp. stock underperforms Wednesday when compared to competitors",
    "summary": "Boston Scientific Corp. stock underperforms Wednesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=8140170be01251784f4a9633d4314794bb37ed0426d62762fabd879a34e8ec3a",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757522100,
      "headline": "Boston Scientific Corp. stock underperforms Wednesday when compared to competitors",
      "id": 136714747,
      "image": "",
      "related": "BSX",
      "source": "MarketWatch",
      "summary": "Boston Scientific Corp. stock underperforms Wednesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=8140170be01251784f4a9633d4314794bb37ed0426d62762fabd879a34e8ec3a"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific inks $88M Elutia deal to challenge Medtronic",
    "summary": "BTIG analysts estimate that Elutia’s Elupro and Medtronic’s TYRX are competing for a $600 million opportunity in the U.S. cardiac rhythm management sector.",
    "url": "https://finnhub.io/api/news?id=86aae2896feb6df6e9e228e127a2eb736f0af2a02319dda18ade7bc9611be8af",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757503200,
      "headline": "Boston Scientific inks $88M Elutia deal to challenge Medtronic",
      "id": 136689247,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "BTIG analysts estimate that Elutia’s Elupro and Medtronic’s TYRX are competing for a $600 million opportunity in the U.S. cardiac rhythm management sector.",
      "url": "https://finnhub.io/api/news?id=86aae2896feb6df6e9e228e127a2eb736f0af2a02319dda18ade7bc9611be8af"
    }
  }
]